Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut bacterial microbiome composition and statin intake—A systematic review
Andréia Dias, Gonçalo Cordeiro, María Manuela Estevinho, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 49

Showing 26-50 of 49 citing articles:

Drug and gut microbe relationships: Moving beyond antibiotics
Shreyas V. Kumbhare, Inti Pedroso, Juan A. Ugalde, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103797-103797
Closed Access | Times Cited: 5
Inflammatory Bowel Disease-Associated Arthritis Is Associated with Concomitant Autoimmune and Inflammatory Disorders
Madeline Alizadeh, Uni Wong, Bernadette Siaton, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 8, pp. 2961-2969
Closed Access | Times Cited: 1
Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
Kwang Seob Lee, Yongin Cho, Hongkyung Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1216-1216
Open Access | Times Cited: 7
Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
Sylwia Dzięgielewska-Gęsiak, Edyta Fatyga, Magdalena Piłot, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3589-3599
Open Access | Times Cited: 7
Potential role of statins in treatment of acute sarcopenia
Anton De Spiegeleer, Hasan Kahya, Liesbeth Crombez, et al.
Medical Hypotheses (2023) Vol. 177, pp. 111111-111111
Closed Access | Times Cited: 3
Statin therapy and gut microbiota
Peng Chen, Kangbao Li
IntechOpen eBooks (2023)
Open Access | Times Cited: 3
Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases
Yogesh Garg, Navjot Kanwar, Shruti Chopra, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 14, pp. 1344-1356
Closed Access | Times Cited: 5
Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study
Xiaoying Zhang, Yuyao Liu, Yanghui Ou, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 2
Statins - From Lipid-Lowering Benefits to Pleiotropic Effects

IntechOpen eBooks (2023)
Open Access | Times Cited: 2
Serum cholesterol increase in statin users associated with antibiotic use: Case-crossover study
Idit Lavi, Naomi Gronich
European Journal of Pharmacology (2022) Vol. 932, pp. 175209-175209
Closed Access | Times Cited: 3
Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study
Lubo Shi, Xiaoduo Liu, Enze Li, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e797-e808
Closed Access
Microbiota and the Cardiovascular System
Óscar Lorenzo, Jairo Lumpuy‐Castillo, Cristina Espadas, et al.
(2024), pp. 81-94
Closed Access
Impact of COVID-19 on gut–lung microbiota a mini review
Reza Emadi, Parastoo Yousefi, Alireza Tabibzadeh
Reviews in Medical Microbiology (2024)
Closed Access
The Ageing Microbiome, Pharmaceutical Considerations, and Therapeutic Opportunities
Alessia Favaron, Laura E. McCoubrey, Moe Elbadawi, et al.
AAPS advances in the pharmaceutical sciences series (2023), pp. 191-230
Closed Access | Times Cited: 1
A two-sample Mendelian randomization study reveals the causal effects of statin medication on gut microbiota abundance in the European population
Peng Zhou, Chen Qiu, Zequn Zhuang, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Clostridioides difficile Infection
David B. Stewart
Clinics in Colon and Rectal Surgery (2020) Vol. 33, Iss. 02, pp. 047-048
Open Access | Times Cited: 2
Drug-Related Enteropathy
O. Gómez-Escudero
IntechOpen eBooks (2022)
Open Access | Times Cited: 1
The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs
Leonie Schoch, Pablo Sutelman, Rosa Suades, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 4
Closed Access | Times Cited: 1
Medication and Health Risks Associated With Neglected Side Effects on Gut Microbiota
Tsvetelina Velikova, Radislav Nakov, Gianluca Ianiro
Elsevier eBooks (2021), pp. 112-124
Closed Access | Times Cited: 1
Advances in Probiotics for Health and Nutrition [Working Title]

IntechOpen eBooks (2023)
Open Access
CORRELAÇÃO DO MICROBIOMA INTESTINAL E DISBIOSE EM PACIENTES COM TRANSTORNO DO ESPECTRO AUTISTA
Beatriz Fernandes Maia, Olívia Paz dos Anjos, Maria do Socorro Francisco de Oliveira, et al.
Revista Ibero-Americana de Humanidades, Ciências e Educação (2023) Vol. 9, Iss. 9, pp. 4569-4579
Open Access
Nonalcoholic Fatty Liver Disease, Procalcitonin, and Gut Microbiota: Players in the Same Team
Doina Georgescu, Ana Lascu, Ioana Ioniţă, et al.
IntechOpen eBooks (2023)
Open Access
Impact drugs targeting cardiometabolic risk on the gut microbiota
Manon Balvers, Bert‐Jan H. van den Born, Evgeni Levin, et al.
Current Opinion in Lipidology (2020) Vol. 32, Iss. 1, pp. 38-54
Closed Access
In vitro impact of the long term medication for blood pressure, diabetes type II and cholesterol medicines on the gut microbiota
Hissah Abdulrahman Alodaini
Journal of King Saud University - Science (2022) Vol. 35, Iss. 1, pp. 102443-102443
Open Access
Previous Page - Page 2

Scroll to top